ECCMID 24th (2014)

Title Content type
Antifungal drug interactions database and apps for iPhone and Android (click for details)
A Phase 3 Randomized, Double-Blind Trial Evaluating Isavuconzole vs. Voriconazole for the Primary Treatment of Invasive Fungal Disease Caused by Aspergillus SPP. or other Filamentous Fungi (SECURE) (click for details)
In vivo efficacy of Isavuconazole and Amphotericin B of in a non-neutropenic murine model of disseminated Absidia corymbifera (click for details)
Pharmacodynamics of the new azole Isavuconazole (ISA) in an Aspergillus fumigatus mouse infection model (click for details)
Determination of susceptibility breakpoints for posaconazole and Aspergillus fumigatus using a pharmacokinetic-pharmacodynamic model (click for details)
First Danish report of TR34/L98H A. fumigatus in three non-cystic fibrosis patients despite apparent lack of resistant isolates in recent soil samples (click for details)
A pharmacokinetic rationale for alternate dosing strategies of anidulafungin (click for details)
Investigation of primary clinical samples and azole-resistant isolates of immunocompromised patients for cyp51A mutations in Aspergillus fumigatus using established and a novel TR46 PCR assays (click for details)
Occurrence and molecular characterisation of triazole-resistant Aspergillus fumigatus in outdoor and hospital environment in Kuwait (click for details)
Identification of novel transcription factors associated with azole resistance in Aspergillus fumigatus (click for details)

Pages

Subscribe to ECCMID 24th (2014)